Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infectionSAJADI, Mohammad M; REDFIELD, Robert R; TALWANI, Rohit et al.AIDS (London). 2013, Vol 27, Num 12, pp 1989-1992, issn 0269-9370, 4 p.Article

Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressorsSAJADI, Mohammad M; PULIJALA, Roopa; REDFIELD, Robert R et al.AIDS (London). 2012, Vol 26, Num 15, pp 1879-1884, issn 0269-9370, 6 p.Article

Hepatitis C infection in HIV-1 natural viral suppressorsSAJADI, Mohammad M; SHAKERI, Nahzinine; TALWANI, Rohit et al.AIDS (London). 2010, Vol 24, Num 11, pp 1689-1695, issn 0269-9370, 7 p.Article

Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist MaravirocLATINOVIC, Olga; SCHNEIDER, Kate; SZMACINSKI, Henryk et al.Antiviral research. 2014, Vol 112, pp 80-90, issn 0166-3542, 11 p.Article

Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFFPARSONS, Ronald F; MING YU; MIGONE, Thi-Sau et al.Transplantation. 2012, Vol 93, Num 7, pp 676-685, issn 0041-1337, 10 p.Article

Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected AdultsJACOBSON, Jeffrey M; SAAG, Michael S; MURGA, Jose D et al.The Journal of infectious diseases. 2008, Vol 198, Num 9, pp 1345-1352, issn 0022-1899, 8 p.Article

Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in AfricaAMOROSO, Anthony; SPENCER, Derek E; REDFIELD, Robert R et al.AIDS (Supplement). 2004, Vol 18, pp S39-S43, issn 1350-2840, SUP3Article

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionLATINOVIC, Olga; LE, Nhut; REITZ, Marvin et al.AIDS (London). 2011, Vol 25, Num 9, pp 1232-1235, issn 0269-9370, 4 p.Article

Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine and Tenofovir DF (Study COL40263)ROSS, Lisa; ELION, Richard; BELINDA HA et al.AIDS research and human retroviruses. 2009, Vol 25, Num 7, pp 665-672, issn 0889-2229, 8 p.Article

Plasmablastic lymphoma of the oral cavity : a rapidly progressive lymphoma associated with HIV infectionRIEDEL, David J; GONZALEZ-CUYAR, Luis F; ZHAO, X. Frank et al.Lancet. Infectious diseases (print). 2008, Vol 8, Num 4, pp 261-267, issn 1473-3099, 7 p.Article

Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patientCHAN-TACK, Kirk M; AHUJA, Navneet; WEINMAN, Edward J et al.The American journal of the medical sciences. 2006, Vol 332, Num 6, pp 364-367, issn 0002-9629, 4 p.Article

Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1HEREDIA, Alonso; DAVIS, Charles; AMIN, Mohammed N et al.AIDS (London). 2014, Vol 28, Num 3, pp 317-323, issn 0269-9370, 7 p.Article

Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral SuppressorsSAJADI, Mohammad M; CONSTANTINE, Neil T; MANN, Dean L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 4, pp 403-408, issn 1525-4135, 6 p.Article

Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonistsLATINOVIC, Olga; HEREDIA, Alonso; GALLO, Robert C et al.Antiviral research. 2009, Vol 83, Num 1, pp 86-89, issn 0166-3542, 4 p.Article

In vitro suppression of latent HIV-1 activation by vitamin E : potential clinical implicationsHEREDIA, Alonso; DAVIS, Charles; AMOROSO, Anthony et al.AIDS (London). 2005, Vol 19, Num 8, pp 836-837, issn 0269-9370, 2 p.Article

High cancer-related mortality in an urban, predominantly African―American, HIV-infected populationRIEDEL, David J; MWANGI, Evelyn Ivy W; FANTRY, Lori E et al.AIDS (London). 2013, Vol 27, Num 7, pp 1109-1117, issn 0269-9370, 9 p.Article

Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human PlasmaSAJADI, Mohammad M; LEWIS, George K; SEAMAN, Michael S et al.Journal of virology. 2012, Vol 86, Num 9, pp 5014-5025, issn 0022-538X, 12 p.Article

Treatment Outcomes of Recommended First-Line Antiretroviral Regimens in Resource-Limited ClinicsAMOROSO, Anthony; ETIENNE-MESUBI, Martine; EDOZIEN, Anthony et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 3, pp 314-320, issn 1525-4135, 7 p.Article

A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-a fusion protein in chronic hepatitis C patients who have failed previous interferon-α-based therapyBALAN, Vijayan; NELSON, David R; NEUMANN, Avidan U et al.Antiviral therapy (London). 2006, Vol 11, Num 1, pp 35-45, issn 1359-6535, 11 p.Article

Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat proteinRUCKWARDT, Tracy J; TIKHONOV, Ilia; BERG, Shannon et al.Journal of virology. 2004, Vol 78, Num 23, pp 13190-13196, issn 0022-538X, 7 p.Article

Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1HEREDIA, Alonso; DAVIS, Charles E; REITZ, Marvin S et al.The Journal of infectious diseases. 2013, Vol 208, Num 12, pp 2085-2094, issn 0022-1899, 10 p.Article

Natural viral suppressors of HIV-1 have a unique capacity to maintain γδ T cellsRIEDEL, David J; SAJADI, Mohammad M; ARMSTRONG, Cheryl L et al.AIDS (London). 2009, Vol 23, Num 15, pp 1955-1964, issn 0269-9370, 10 p.Article

Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies : Lessons learnedREISLER, Ronald B; MURPHY, Robert L; REDFIELD, Robert R et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 159-166, issn 1525-4135, 8 p.Article

Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an hiv-1-seropositive cohortRATTO-KIM, Silvia; GARNER, Robin P; KIM, Jerome H et al.The Journal of infectious diseases. 2004, Vol 189, Num 11, pp 1988-1995, issn 0022-1899, 8 p.Article

Impact of Persistent HIV Replication on CD4 Negative Vγ2Vδ2 T CellsBOUDOVA, Sarah; HAISHAN LI; SAJADI, Mohammad M et al.The Journal of infectious diseases. 2012, Vol 205, Num 9, pp 1448-1455, issn 0022-1899, 8 p.Article